"In different clinics, different issues matter, so there is no one size fits all solution," said Dohan. "For example, in a public clinic, they may have translators, but not translators that are equipped to cross cultural barriers in clinical trials."
In private practice and academic settings, clinicians are often rewarded for recruiting patients into clinical trials, but they are not rewarded more for recruiting harder to reach minority patients.
"In a private practice where you have to watch the bottom line, the likelihood is that most of the recruitment is going to pharmaceutical trials, which tend to provide more incentive and do not necessarily require minority recruitment," said Dohan.
#B77. Cancer screening in older South Asian immigrants in United States
New data among South Asian immigrants confirms that cancer screening rates are low largely due a lack of knowledge about available services and the benefits of screening.
Abhijit S. Prabhughate, a doctoral candidate at the Jane Addams College of Social Work at UIC in Chicago, said more research is needed to understand the cultural sensitivities in this population.
"South Asian-Americans are an understudied group. More than 40 percent of the South Asian immigrants in our study did not have health insurance and little is known about their risk," said Prabhughate.
Of 331 total surveyed people, 84 percent were born in India and 14 percent were born in Pakistan. Although 57 percent of them had lived in the United States for a decade or more, only 65 percent had a regular family doctor.
These immigrants were likely to not be screened for breast cancer for the following reasons: not wanting to know if one had cancer, family not wanting the individual to get tested, embarrassment, fear of losing job, language difficulties, and not knowing where to get tested.
They were mor
|Contact: Jeremy Moore|
American Association for Cancer Research